The symposium will provide a comprehensive and clinically focused overview of bispecific therapies and their role in oncology. Topics will include review of bispecific agents, mechanism of action, and their clinical indications. Emphasis will be placed on administration, monitoring, and the management of side effects, including treatment-emergent complications. The education program will conclude with a focus on patient education and care coordination strategies that support optimal outcomes for patients receiving bispecific therapies.
Provider approved by the California Board of Registered Nursing, provider number CEP 26, for 3.5 contact hours.
Oncology Series: Advancing Care with Bispecific Therapies - A Clinical Symposium
Code: DAHS-NGNACBTCS26OM-BRN
Estimated Duration: 3 hours and 30 minutes
Start
Sandy Phan, D.N.P., R.N., N.P.D.A.-B.C., E.B.P.-C.
Professional Development Specialist
For questions or assistance with the UC Learning Center, please contact us at LMSProblem@health.ucdavis.edu.